Literature DB >> 17482564

Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Hiroyuki Kobori1, Akemi Katsurada, Yuri Ozawa, Ryousuke Satou, Kayoko Miyata, Naoki Hase, Yuki Suzaki, Tatsuya Shoji.   

Abstract

This study was performed to determine whether immunoreactivity of intrarenal hemeoxygenase-1 and angiotensinogen are increased in IgA nephropathy (IgAN) patients. Hemeoxygenase-1 and angiotensinogen immunoreactivity were determined by immunohistochemistry robot system in renal specimens from 39 patients with IgAN. Normal portions of surgically resected kidney served as controls. IgAN patients showed moderate proteinuria (1.1+/-0.2 g/day); however, the control group did not show any proteinuria. Immunoreactivity of intrarenal hemeoxygenase-1 and angiotensinogen in IgAN were significantly increased compared to normal kidneys (2.42+/-0.42 vs 1.00+/-0.26 for hemeoxygenase-1 and 4.05+/-0.40 vs 1.00+/-0.21 for angiotensinogen, arbitrary unit). Even though these IgAN patients did not show massive renal damage, hemeoxygenase-1 and angiotensinogen immunoreactivity were increased in these patients at this time point. These data suggest that activated intrarenal reactive oxygen species-angiotensinogen axis plays some roles in development of IgAN at the early stage and will provide supportive foundation of effectiveness of the renin-angiotensin system blockade in IgAN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482564      PMCID: PMC1978415          DOI: 10.1016/j.bbrc.2007.04.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  53 in total

Review 1.  IgA nephropathy.

Authors:  Jonathan Barratt; John Feehally
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

2.  Quantification of human angiotensinogen by a novel sandwich ELISA.

Authors:  Yuki Suzaki; Yuri Ozawa; Hiroyuki Kobori
Journal:  Peptides       Date:  2006-06-21       Impact factor: 3.750

3.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

4.  Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.

Authors:  Loretta Y Y Chan; Joseph C K Leung; Sydney C W Tang; Cindy B Y Choy; Kar Neng Lai
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

5.  Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease.

Authors:  Tatsuo Yamamoto; Tsutomu Nakagawa; Hiroyuki Suzuki; Naro Ohashi; Hirotaka Fukasawa; Yoshihide Fujigaki; Akihiko Kato; Yukio Nakamura; Fumiaki Suzuki; Akira Hishida
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

6.  Epidemiologic data of primary glomerular diseases in western France.

Authors:  Pierre Simon; Marie-Paule Ramee; Rehouni Boulahrouz; Corina Stanescu; Christophe Charasse; Kim Seng Ang; Françoise Leonetti; Gérard Cam; Eric Laruelle; Valérie Autuly; Nathalie Rioux
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?

Authors:  R Nair; P D Walker
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

8.  Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Lisa M Harrison-Bernard; Hiroyuki Kobori; Yuri Ozawa; Kathleen S Hering-Smith; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2004-06-28       Impact factor: 10.190

Review 9.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.

Authors:  John J Dillon
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

10.  Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.

Authors:  Yuki Suzaki; Yuri Ozawa; Hiroyuki Kobori
Journal:  Int J Biol Sci       Date:  2006-11-01       Impact factor: 6.580

View more
  47 in total

1.  Evaluation of kidney dysfunction and angiotensinogen as an early novel biomarker of intrauterine growth restricted offspring rats.

Authors:  Yayoi Murano; Naoto Nishizaki; Amane Endo; Naho Ikeda; Tomonosuke Someya; Mayu Nakagawa; Taichi Hara; Koji Sakuraya; Satoshi Hara; Daishi Hirano; Mitsuyoshi Suzuki; Hiromichi Shoji; Shuichiro Fujinaga; Yoshiyuki Ohtomo; Toshiaki Shimizu
Journal:  Pediatr Res       Date:  2015-08-13       Impact factor: 3.756

Review 2.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

3.  Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.

Authors:  Yoshio Konishi; Akira Nishiyama; Takashi Morikawa; Chizuko Kitabayashi; Mikiko Shibata; Masahiro Hamada; Masatsugu Kishida; Hirofumi Hitomi; Hideyasu Kiyomoto; Takenori Miyashita; Nozomu Mori; Maki Urushihara; Hiroyuki Kobori; Masahito Imanishi
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

4.  Increased nocturnal blood pressure variability is associated with renal arteriolar hyalinosis in normotensive patients with IgA nephropathy.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Hideo Yasuda
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

5.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

6.  Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation.

Authors:  Yanhong Wang; Jihua Tian; Haixiu Guo; Yang Mi; Ruijing Zhang; Rongshan Li
Journal:  Clin Exp Med       Date:  2015-04-28       Impact factor: 3.984

7.  Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases.

Authors:  Hiroyuki Kobori; Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Tatsuo Yamamoto
Journal:  J Am Soc Hypertens       Date:  2008 Sep-Oct

8.  Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-03-02       Impact factor: 2.557

9.  Immunosuppressive therapy for active IgA nephropathy is effective and safe, even in "elderly" patients.

Authors:  Michio Fukuda; Osamu Hotta; Masashi Mizuno; Yoshiaki Ogiyama; Nobuyuki Ohte
Journal:  Clin Exp Nephrol       Date:  2016-07-21       Impact factor: 2.801

10.  Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Kayoko Miyata; Naro Ohashi; Ryousuke Satou; Toshie Saito; Yoshiaki Hagiwara; Kazuya Miyashita; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.